Home/Filings/4/0000950170-25-074659
4//SEC Filing

FORD KATHLEEN 4

Accession 0000950170-25-074659

CIK 0001422143other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 6:30 PM ET

Size

5.4 KB

Accession

0000950170-25-074659

Insider Transaction Report

Form 4
Period: 2025-05-19
FORD KATHLEEN
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2025-05-19$6.28/sh1,558$9,77721,367 total
Footnotes (3)
  • [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2024.
  • [F2]1,558 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.
  • [F3]This transaction was executed in multiple trades at prices ranging from $6.27 to $6.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeother

Related Parties

1
  • filerCIK 0001785406

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 6:30 PM ET
Size
5.4 KB